nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—AKR1C3—Doxorubicin—hematologic cancer	0.168	1	CbGbCtD
Bimatoprost—PTGFR—ovarian follicle—hematologic cancer	0.0701	0.591	CbGeAlD
Bimatoprost—PTGER3—lung—hematologic cancer	0.00615	0.0518	CbGeAlD
Bimatoprost—PTGER3—testis—hematologic cancer	0.0058	0.0489	CbGeAlD
Bimatoprost—PTGFR—lung—hematologic cancer	0.00492	0.0414	CbGeAlD
Bimatoprost—PTGFR—testis—hematologic cancer	0.00464	0.0391	CbGeAlD
Bimatoprost—AKR1C3—blood—hematologic cancer	0.00456	0.0384	CbGeAlD
Bimatoprost—AKR1C3—bone marrow—hematologic cancer	0.00441	0.0372	CbGeAlD
Bimatoprost—PTGER3—lymph node—hematologic cancer	0.00421	0.0354	CbGeAlD
Bimatoprost—AKR1C3—lung—hematologic cancer	0.00399	0.0337	CbGeAlD
Bimatoprost—AKR1C3—testis—hematologic cancer	0.00377	0.0318	CbGeAlD
Bimatoprost—PTGFR—lymph node—hematologic cancer	0.00336	0.0283	CbGeAlD
Bimatoprost—AKR1C3—lymph node—hematologic cancer	0.00273	0.023	CbGeAlD
Bimatoprost—AKR1C3—Podofilox—Teniposide—hematologic cancer	0.0025	0.273	CbGdCrCtD
Bimatoprost—Dinoprostone—PTGER4—hematologic cancer	0.00203	0.302	CrCbGaD
Bimatoprost—Iloprost—PDE4B—hematologic cancer	0.00202	0.301	CrCbGaD
Bimatoprost—Latanoprost—SLC22A1—hematologic cancer	0.00195	0.29	CrCbGaD
Bimatoprost—AKR1C3—Vincristine—Vinorelbine—hematologic cancer	0.00159	0.174	CbGdCrCtD
Bimatoprost—AKR1C3—Podofilox—Etoposide—hematologic cancer	0.00148	0.162	CbGdCrCtD
Bimatoprost—AKR1C3—Vinblastine—Vinorelbine—hematologic cancer	0.00128	0.14	CbGdCrCtD
Bimatoprost—AKR1C3—Vincristine—Vinblastine—hematologic cancer	0.00127	0.139	CbGdCrCtD
Bimatoprost—AKR1C3—Vinblastine—Vincristine—hematologic cancer	0.00102	0.112	CbGdCrCtD
Bimatoprost—Dinoprostone—SLC22A1—hematologic cancer	0.000722	0.107	CrCbGaD
Bimatoprost—Dermatitis—Bleomycin—hematologic cancer	0.000112	0.00025	CcSEcCtD
Bimatoprost—Asthenia—Carmustine—hematologic cancer	0.000111	0.000249	CcSEcCtD
Bimatoprost—Dry mouth—Triamcinolone—hematologic cancer	0.000111	0.000248	CcSEcCtD
Bimatoprost—Dizziness—Thiotepa—hematologic cancer	0.00011	0.000247	CcSEcCtD
Bimatoprost—Asthenia—Alitretinoin—hematologic cancer	0.00011	0.000247	CcSEcCtD
Bimatoprost—Rash—Vinorelbine—hematologic cancer	0.00011	0.000247	CcSEcCtD
Bimatoprost—Dermatitis—Vinorelbine—hematologic cancer	0.00011	0.000246	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Epirubicin—hematologic cancer	0.00011	0.000246	CcSEcCtD
Bimatoprost—Angiopathy—Prednisone—hematologic cancer	0.00011	0.000246	CcSEcCtD
Bimatoprost—Headache—Vinorelbine—hematologic cancer	0.000109	0.000245	CcSEcCtD
Bimatoprost—Asthma—Doxorubicin—hematologic cancer	0.000109	0.000245	CcSEcCtD
Bimatoprost—Asthenia—Ifosfamide—hematologic cancer	0.000109	0.000244	CcSEcCtD
Bimatoprost—Pruritus—Alitretinoin—hematologic cancer	0.000108	0.000243	CcSEcCtD
Bimatoprost—Vertigo—Dexamethasone—hematologic cancer	0.000108	0.000243	CcSEcCtD
Bimatoprost—Vertigo—Betamethasone—hematologic cancer	0.000108	0.000243	CcSEcCtD
Bimatoprost—Infection—Triamcinolone—hematologic cancer	0.000108	0.000242	CcSEcCtD
Bimatoprost—Pruritus—Ifosfamide—hematologic cancer	0.000107	0.00024	CcSEcCtD
Bimatoprost—Insomnia—Prednisolone—hematologic cancer	0.000107	0.000239	CcSEcCtD
Bimatoprost—Dyspnoea—Etoposide—hematologic cancer	0.000107	0.000239	CcSEcCtD
Bimatoprost—Dizziness—Thalidomide—hematologic cancer	0.000107	0.000239	CcSEcCtD
Bimatoprost—Somnolence—Etoposide—hematologic cancer	0.000106	0.000239	CcSEcCtD
Bimatoprost—Nausea—Bortezomib—hematologic cancer	0.000106	0.000238	CcSEcCtD
Bimatoprost—Asthenia—Vincristine—hematologic cancer	0.000106	0.000238	CcSEcCtD
Bimatoprost—Nausea—Bleomycin—hematologic cancer	0.000105	0.000236	CcSEcCtD
Bimatoprost—Erythema—Prednisone—hematologic cancer	0.000105	0.000236	CcSEcCtD
Bimatoprost—Rash—Thiotepa—hematologic cancer	0.000105	0.000236	CcSEcCtD
Bimatoprost—Bronchitis—Doxorubicin—hematologic cancer	0.000105	0.000235	CcSEcCtD
Bimatoprost—Dermatitis—Thiotepa—hematologic cancer	0.000105	0.000235	CcSEcCtD
Bimatoprost—Headache—Thiotepa—hematologic cancer	0.000104	0.000234	CcSEcCtD
Bimatoprost—Hypertension—Dexamethasone—hematologic cancer	0.000104	0.000234	CcSEcCtD
Bimatoprost—Hypertension—Betamethasone—hematologic cancer	0.000104	0.000234	CcSEcCtD
Bimatoprost—Nausea—Vinorelbine—hematologic cancer	0.000104	0.000232	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000103	0.000232	CcSEcCtD
Bimatoprost—Asthenia—Irinotecan—hematologic cancer	0.000103	0.000232	CcSEcCtD
Bimatoprost—Asthenia—Mitoxantrone—hematologic cancer	0.000103	0.000232	CcSEcCtD
Bimatoprost—Anxiety—Dexamethasone—hematologic cancer	0.000102	0.00023	CcSEcCtD
Bimatoprost—Anxiety—Betamethasone—hematologic cancer	0.000102	0.00023	CcSEcCtD
Bimatoprost—Dizziness—Carmustine—hematologic cancer	0.000102	0.00023	CcSEcCtD
Bimatoprost—Pain—Etoposide—hematologic cancer	0.000102	0.00023	CcSEcCtD
Bimatoprost—Rash—Thalidomide—hematologic cancer	0.000102	0.000228	CcSEcCtD
Bimatoprost—Dermatitis—Thalidomide—hematologic cancer	0.000102	0.000228	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Doxorubicin—hematologic cancer	0.000101	0.000228	CcSEcCtD
Bimatoprost—Dizziness—Alitretinoin—hematologic cancer	0.000101	0.000227	CcSEcCtD
Bimatoprost—Headache—Thalidomide—hematologic cancer	0.000101	0.000226	CcSEcCtD
Bimatoprost—Pain—Prednisolone—hematologic cancer	0.000101	0.000226	CcSEcCtD
Bimatoprost—Asthenia—Gemcitabine—hematologic cancer	0.000101	0.000226	CcSEcCtD
Bimatoprost—Dizziness—Ifosfamide—hematologic cancer	0.0001	0.000225	CcSEcCtD
Bimatoprost—Pharyngitis—Methotrexate—hematologic cancer	0.0001	0.000225	CcSEcCtD
Bimatoprost—Pruritus—Gemcitabine—hematologic cancer	9.92e-05	0.000222	CcSEcCtD
Bimatoprost—Vision blurred—Prednisone—hematologic cancer	9.9e-05	0.000222	CcSEcCtD
Bimatoprost—Nausea—Thiotepa—hematologic cancer	9.9e-05	0.000222	CcSEcCtD
Bimatoprost—Sinusitis—Epirubicin—hematologic cancer	9.87e-05	0.000221	CcSEcCtD
Bimatoprost—Insomnia—Triamcinolone—hematologic cancer	9.82e-05	0.00022	CcSEcCtD
Bimatoprost—Infection—Dexamethasone—hematologic cancer	9.78e-05	0.000219	CcSEcCtD
Bimatoprost—Infection—Betamethasone—hematologic cancer	9.78e-05	0.000219	CcSEcCtD
Bimatoprost—Dizziness—Vincristine—hematologic cancer	9.77e-05	0.000219	CcSEcCtD
Bimatoprost—Rash—Carmustine—hematologic cancer	9.76e-05	0.000219	CcSEcCtD
Bimatoprost—Dermatitis—Carmustine—hematologic cancer	9.75e-05	0.000219	CcSEcCtD
Bimatoprost—Visual impairment—Methotrexate—hematologic cancer	9.72e-05	0.000218	CcSEcCtD
Bimatoprost—Headache—Carmustine—hematologic cancer	9.7e-05	0.000217	CcSEcCtD
Bimatoprost—Dyspnoea—Triamcinolone—hematologic cancer	9.68e-05	0.000217	CcSEcCtD
Bimatoprost—Rash—Alitretinoin—hematologic cancer	9.67e-05	0.000217	CcSEcCtD
Bimatoprost—Nervous system disorder—Dexamethasone—hematologic cancer	9.66e-05	0.000217	CcSEcCtD
Bimatoprost—Nervous system disorder—Betamethasone—hematologic cancer	9.66e-05	0.000217	CcSEcCtD
Bimatoprost—Dermatitis—Alitretinoin—hematologic cancer	9.66e-05	0.000217	CcSEcCtD
Bimatoprost—Headache—Alitretinoin—hematologic cancer	9.6e-05	0.000215	CcSEcCtD
Bimatoprost—Nausea—Thalidomide—hematologic cancer	9.57e-05	0.000215	CcSEcCtD
Bimatoprost—Dyspepsia—Triamcinolone—hematologic cancer	9.55e-05	0.000214	CcSEcCtD
Bimatoprost—Rash—Ifosfamide—hematologic cancer	9.55e-05	0.000214	CcSEcCtD
Bimatoprost—Dermatitis—Ifosfamide—hematologic cancer	9.54e-05	0.000214	CcSEcCtD
Bimatoprost—Dizziness—Irinotecan—hematologic cancer	9.51e-05	0.000213	CcSEcCtD
Bimatoprost—Rhinitis—Epirubicin—hematologic cancer	9.47e-05	0.000212	CcSEcCtD
Bimatoprost—Vertigo—Prednisone—hematologic cancer	9.44e-05	0.000212	CcSEcCtD
Bimatoprost—Eye disorder—Methotrexate—hematologic cancer	9.43e-05	0.000211	CcSEcCtD
Bimatoprost—Asthenia—Cisplatin—hematologic cancer	9.37e-05	0.00021	CcSEcCtD
Bimatoprost—Pharyngitis—Epirubicin—hematologic cancer	9.37e-05	0.00021	CcSEcCtD
Bimatoprost—Rash—Vincristine—hematologic cancer	9.31e-05	0.000209	CcSEcCtD
Bimatoprost—Dermatitis—Vincristine—hematologic cancer	9.31e-05	0.000209	CcSEcCtD
Bimatoprost—Oedema peripheral—Epirubicin—hematologic cancer	9.3e-05	0.000209	CcSEcCtD
Bimatoprost—Pain—Triamcinolone—hematologic cancer	9.28e-05	0.000208	CcSEcCtD
Bimatoprost—Connective tissue disorder—Epirubicin—hematologic cancer	9.28e-05	0.000208	CcSEcCtD
Bimatoprost—Headache—Vincristine—hematologic cancer	9.25e-05	0.000208	CcSEcCtD
Bimatoprost—Nausea—Carmustine—hematologic cancer	9.19e-05	0.000206	CcSEcCtD
Bimatoprost—Angiopathy—Methotrexate—hematologic cancer	9.15e-05	0.000205	CcSEcCtD
Bimatoprost—Sinusitis—Doxorubicin—hematologic cancer	9.13e-05	0.000205	CcSEcCtD
Bimatoprost—Nausea—Alitretinoin—hematologic cancer	9.11e-05	0.000204	CcSEcCtD
Bimatoprost—Visual impairment—Epirubicin—hematologic cancer	9.1e-05	0.000204	CcSEcCtD
Bimatoprost—Mediastinal disorder—Methotrexate—hematologic cancer	9.09e-05	0.000204	CcSEcCtD
Bimatoprost—Hypertension—Prednisone—hematologic cancer	9.07e-05	0.000204	CcSEcCtD
Bimatoprost—Rash—Mitoxantrone—hematologic cancer	9.07e-05	0.000203	CcSEcCtD
Bimatoprost—Rash—Irinotecan—hematologic cancer	9.07e-05	0.000203	CcSEcCtD
Bimatoprost—Dermatitis—Irinotecan—hematologic cancer	9.06e-05	0.000203	CcSEcCtD
Bimatoprost—Dermatitis—Mitoxantrone—hematologic cancer	9.06e-05	0.000203	CcSEcCtD
Bimatoprost—Headache—Irinotecan—hematologic cancer	9.01e-05	0.000202	CcSEcCtD
Bimatoprost—Headache—Mitoxantrone—hematologic cancer	9.01e-05	0.000202	CcSEcCtD
Bimatoprost—Nausea—Ifosfamide—hematologic cancer	9e-05	0.000202	CcSEcCtD
Bimatoprost—Anxiety—Prednisone—hematologic cancer	8.92e-05	0.0002	CcSEcCtD
Bimatoprost—Insomnia—Dexamethasone—hematologic cancer	8.91e-05	0.0002	CcSEcCtD
Bimatoprost—Insomnia—Betamethasone—hematologic cancer	8.91e-05	0.0002	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	8.89e-05	0.000199	CcSEcCtD
Bimatoprost—Rash—Gemcitabine—hematologic cancer	8.84e-05	0.000198	CcSEcCtD
Bimatoprost—Dermatitis—Gemcitabine—hematologic cancer	8.83e-05	0.000198	CcSEcCtD
Bimatoprost—Eye disorder—Epirubicin—hematologic cancer	8.82e-05	0.000198	CcSEcCtD
Bimatoprost—Erythema—Methotrexate—hematologic cancer	8.78e-05	0.000197	CcSEcCtD
Bimatoprost—Headache—Gemcitabine—hematologic cancer	8.78e-05	0.000197	CcSEcCtD
Bimatoprost—Nausea—Vincristine—hematologic cancer	8.78e-05	0.000197	CcSEcCtD
Bimatoprost—Rhinitis—Doxorubicin—hematologic cancer	8.76e-05	0.000196	CcSEcCtD
Bimatoprost—Pharyngitis—Doxorubicin—hematologic cancer	8.67e-05	0.000194	CcSEcCtD
Bimatoprost—Dyspepsia—Dexamethasone—hematologic cancer	8.67e-05	0.000194	CcSEcCtD
Bimatoprost—Dyspepsia—Betamethasone—hematologic cancer	8.67e-05	0.000194	CcSEcCtD
Bimatoprost—Oedema peripheral—Doxorubicin—hematologic cancer	8.61e-05	0.000193	CcSEcCtD
Bimatoprost—Asthenia—Etoposide—hematologic cancer	8.59e-05	0.000193	CcSEcCtD
Bimatoprost—Connective tissue disorder—Doxorubicin—hematologic cancer	8.59e-05	0.000193	CcSEcCtD
Bimatoprost—Angiopathy—Epirubicin—hematologic cancer	8.57e-05	0.000192	CcSEcCtD
Bimatoprost—Nausea—Irinotecan—hematologic cancer	8.55e-05	0.000192	CcSEcCtD
Bimatoprost—Nausea—Mitoxantrone—hematologic cancer	8.55e-05	0.000192	CcSEcCtD
Bimatoprost—Infection—Prednisone—hematologic cancer	8.52e-05	0.000191	CcSEcCtD
Bimatoprost—Mediastinal disorder—Epirubicin—hematologic cancer	8.51e-05	0.000191	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Dexamethasone—hematologic cancer	8.5e-05	0.000191	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Betamethasone—hematologic cancer	8.5e-05	0.000191	CcSEcCtD
Bimatoprost—Pruritus—Etoposide—hematologic cancer	8.47e-05	0.00019	CcSEcCtD
Bimatoprost—Pain—Dexamethasone—hematologic cancer	8.42e-05	0.000189	CcSEcCtD
Bimatoprost—Pain—Betamethasone—hematologic cancer	8.42e-05	0.000189	CcSEcCtD
Bimatoprost—Visual impairment—Doxorubicin—hematologic cancer	8.42e-05	0.000189	CcSEcCtD
Bimatoprost—Nervous system disorder—Prednisone—hematologic cancer	8.41e-05	0.000189	CcSEcCtD
Bimatoprost—Skin disorder—Prednisone—hematologic cancer	8.33e-05	0.000187	CcSEcCtD
Bimatoprost—Nausea—Gemcitabine—hematologic cancer	8.32e-05	0.000187	CcSEcCtD
Bimatoprost—Vision blurred—Methotrexate—hematologic cancer	8.28e-05	0.000186	CcSEcCtD
Bimatoprost—Rash—Cisplatin—hematologic cancer	8.24e-05	0.000185	CcSEcCtD
Bimatoprost—Dermatitis—Cisplatin—hematologic cancer	8.23e-05	0.000185	CcSEcCtD
Bimatoprost—Erythema—Epirubicin—hematologic cancer	8.22e-05	0.000184	CcSEcCtD
Bimatoprost—Eye disorder—Doxorubicin—hematologic cancer	8.16e-05	0.000183	CcSEcCtD
Bimatoprost—Tension—Epirubicin—hematologic cancer	8.07e-05	0.000181	CcSEcCtD
Bimatoprost—Nervousness—Epirubicin—hematologic cancer	7.98e-05	0.000179	CcSEcCtD
Bimatoprost—Angiopathy—Doxorubicin—hematologic cancer	7.93e-05	0.000178	CcSEcCtD
Bimatoprost—Dizziness—Etoposide—hematologic cancer	7.91e-05	0.000177	CcSEcCtD
Bimatoprost—Vertigo—Methotrexate—hematologic cancer	7.89e-05	0.000177	CcSEcCtD
Bimatoprost—Mediastinal disorder—Doxorubicin—hematologic cancer	7.87e-05	0.000177	CcSEcCtD
Bimatoprost—Dizziness—Prednisolone—hematologic cancer	7.81e-05	0.000175	CcSEcCtD
Bimatoprost—Asthenia—Triamcinolone—hematologic cancer	7.79e-05	0.000175	CcSEcCtD
Bimatoprost—Nausea—Cisplatin—hematologic cancer	7.76e-05	0.000174	CcSEcCtD
Bimatoprost—Insomnia—Prednisone—hematologic cancer	7.76e-05	0.000174	CcSEcCtD
Bimatoprost—Vision blurred—Epirubicin—hematologic cancer	7.75e-05	0.000174	CcSEcCtD
Bimatoprost—Pruritus—Triamcinolone—hematologic cancer	7.68e-05	0.000172	CcSEcCtD
Bimatoprost—Cough—Methotrexate—hematologic cancer	7.66e-05	0.000172	CcSEcCtD
Bimatoprost—Erythema—Doxorubicin—hematologic cancer	7.61e-05	0.000171	CcSEcCtD
Bimatoprost—Dyspepsia—Prednisone—hematologic cancer	7.55e-05	0.000169	CcSEcCtD
Bimatoprost—Rash—Etoposide—hematologic cancer	7.55e-05	0.000169	CcSEcCtD
Bimatoprost—Dermatitis—Etoposide—hematologic cancer	7.54e-05	0.000169	CcSEcCtD
Bimatoprost—Headache—Etoposide—hematologic cancer	7.5e-05	0.000168	CcSEcCtD
Bimatoprost—Chest pain—Methotrexate—hematologic cancer	7.48e-05	0.000168	CcSEcCtD
Bimatoprost—Tension—Doxorubicin—hematologic cancer	7.46e-05	0.000167	CcSEcCtD
Bimatoprost—Rash—Prednisolone—hematologic cancer	7.44e-05	0.000167	CcSEcCtD
Bimatoprost—Dermatitis—Prednisolone—hematologic cancer	7.44e-05	0.000167	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	7.43e-05	0.000167	CcSEcCtD
Bimatoprost—Headache—Prednisolone—hematologic cancer	7.39e-05	0.000166	CcSEcCtD
Bimatoprost—Nervousness—Doxorubicin—hematologic cancer	7.39e-05	0.000166	CcSEcCtD
Bimatoprost—Vertigo—Epirubicin—hematologic cancer	7.38e-05	0.000166	CcSEcCtD
Bimatoprost—Palpitations—Epirubicin—hematologic cancer	7.26e-05	0.000163	CcSEcCtD
Bimatoprost—Dizziness—Triamcinolone—hematologic cancer	7.18e-05	0.000161	CcSEcCtD
Bimatoprost—Cough—Epirubicin—hematologic cancer	7.17e-05	0.000161	CcSEcCtD
Bimatoprost—Vision blurred—Doxorubicin—hematologic cancer	7.17e-05	0.000161	CcSEcCtD
Bimatoprost—Infection—Methotrexate—hematologic cancer	7.12e-05	0.00016	CcSEcCtD
Bimatoprost—Nausea—Etoposide—hematologic cancer	7.11e-05	0.000159	CcSEcCtD
Bimatoprost—Hypertension—Epirubicin—hematologic cancer	7.1e-05	0.000159	CcSEcCtD
Bimatoprost—Asthenia—Betamethasone—hematologic cancer	7.07e-05	0.000158	CcSEcCtD
Bimatoprost—Asthenia—Dexamethasone—hematologic cancer	7.07e-05	0.000158	CcSEcCtD
Bimatoprost—Nervous system disorder—Methotrexate—hematologic cancer	7.03e-05	0.000158	CcSEcCtD
Bimatoprost—Nausea—Prednisolone—hematologic cancer	7.01e-05	0.000157	CcSEcCtD
Bimatoprost—Chest pain—Epirubicin—hematologic cancer	7e-05	0.000157	CcSEcCtD
Bimatoprost—Anxiety—Epirubicin—hematologic cancer	6.97e-05	0.000156	CcSEcCtD
Bimatoprost—Pruritus—Dexamethasone—hematologic cancer	6.97e-05	0.000156	CcSEcCtD
Bimatoprost—Pruritus—Betamethasone—hematologic cancer	6.97e-05	0.000156	CcSEcCtD
Bimatoprost—Skin disorder—Methotrexate—hematologic cancer	6.96e-05	0.000156	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	6.95e-05	0.000156	CcSEcCtD
Bimatoprost—Rash—Triamcinolone—hematologic cancer	6.84e-05	0.000154	CcSEcCtD
Bimatoprost—Dry mouth—Epirubicin—hematologic cancer	6.84e-05	0.000153	CcSEcCtD
Bimatoprost—Dermatitis—Triamcinolone—hematologic cancer	6.84e-05	0.000153	CcSEcCtD
Bimatoprost—Vertigo—Doxorubicin—hematologic cancer	6.83e-05	0.000153	CcSEcCtD
Bimatoprost—Headache—Triamcinolone—hematologic cancer	6.8e-05	0.000153	CcSEcCtD
Bimatoprost—Palpitations—Doxorubicin—hematologic cancer	6.72e-05	0.000151	CcSEcCtD
Bimatoprost—Infection—Epirubicin—hematologic cancer	6.66e-05	0.000149	CcSEcCtD
Bimatoprost—Cough—Doxorubicin—hematologic cancer	6.64e-05	0.000149	CcSEcCtD
Bimatoprost—Nervous system disorder—Epirubicin—hematologic cancer	6.58e-05	0.000148	CcSEcCtD
Bimatoprost—Hypertension—Doxorubicin—hematologic cancer	6.57e-05	0.000147	CcSEcCtD
Bimatoprost—Skin disorder—Epirubicin—hematologic cancer	6.52e-05	0.000146	CcSEcCtD
Bimatoprost—Dizziness—Dexamethasone—hematologic cancer	6.51e-05	0.000146	CcSEcCtD
Bimatoprost—Dizziness—Betamethasone—hematologic cancer	6.51e-05	0.000146	CcSEcCtD
Bimatoprost—Insomnia—Methotrexate—hematologic cancer	6.48e-05	0.000145	CcSEcCtD
Bimatoprost—Chest pain—Doxorubicin—hematologic cancer	6.47e-05	0.000145	CcSEcCtD
Bimatoprost—Anxiety—Doxorubicin—hematologic cancer	6.45e-05	0.000145	CcSEcCtD
Bimatoprost—Nausea—Triamcinolone—hematologic cancer	6.45e-05	0.000145	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	6.43e-05	0.000144	CcSEcCtD
Bimatoprost—Dyspnoea—Methotrexate—hematologic cancer	6.39e-05	0.000143	CcSEcCtD
Bimatoprost—Somnolence—Methotrexate—hematologic cancer	6.37e-05	0.000143	CcSEcCtD
Bimatoprost—Dry mouth—Doxorubicin—hematologic cancer	6.33e-05	0.000142	CcSEcCtD
Bimatoprost—Dyspepsia—Methotrexate—hematologic cancer	6.31e-05	0.000142	CcSEcCtD
Bimatoprost—Rash—Betamethasone—hematologic cancer	6.21e-05	0.000139	CcSEcCtD
Bimatoprost—Rash—Dexamethasone—hematologic cancer	6.21e-05	0.000139	CcSEcCtD
Bimatoprost—Dermatitis—Betamethasone—hematologic cancer	6.2e-05	0.000139	CcSEcCtD
Bimatoprost—Dermatitis—Dexamethasone—hematologic cancer	6.2e-05	0.000139	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Methotrexate—hematologic cancer	6.19e-05	0.000139	CcSEcCtD
Bimatoprost—Headache—Betamethasone—hematologic cancer	6.17e-05	0.000138	CcSEcCtD
Bimatoprost—Headache—Dexamethasone—hematologic cancer	6.17e-05	0.000138	CcSEcCtD
Bimatoprost—Infection—Doxorubicin—hematologic cancer	6.17e-05	0.000138	CcSEcCtD
Bimatoprost—Asthenia—Prednisone—hematologic cancer	6.15e-05	0.000138	CcSEcCtD
Bimatoprost—Pain—Methotrexate—hematologic cancer	6.13e-05	0.000137	CcSEcCtD
Bimatoprost—Nervous system disorder—Doxorubicin—hematologic cancer	6.09e-05	0.000137	CcSEcCtD
Bimatoprost—Pruritus—Prednisone—hematologic cancer	6.07e-05	0.000136	CcSEcCtD
Bimatoprost—Insomnia—Epirubicin—hematologic cancer	6.07e-05	0.000136	CcSEcCtD
Bimatoprost—Skin disorder—Doxorubicin—hematologic cancer	6.03e-05	0.000135	CcSEcCtD
Bimatoprost—Dyspnoea—Epirubicin—hematologic cancer	5.98e-05	0.000134	CcSEcCtD
Bimatoprost—Somnolence—Epirubicin—hematologic cancer	5.96e-05	0.000134	CcSEcCtD
Bimatoprost—Dyspepsia—Epirubicin—hematologic cancer	5.91e-05	0.000132	CcSEcCtD
Bimatoprost—Nausea—Betamethasone—hematologic cancer	5.85e-05	0.000131	CcSEcCtD
Bimatoprost—Nausea—Dexamethasone—hematologic cancer	5.85e-05	0.000131	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Epirubicin—hematologic cancer	5.79e-05	0.00013	CcSEcCtD
Bimatoprost—Pain—Epirubicin—hematologic cancer	5.74e-05	0.000129	CcSEcCtD
Bimatoprost—Dizziness—Prednisone—hematologic cancer	5.67e-05	0.000127	CcSEcCtD
Bimatoprost—Insomnia—Doxorubicin—hematologic cancer	5.61e-05	0.000126	CcSEcCtD
Bimatoprost—Dyspnoea—Doxorubicin—hematologic cancer	5.53e-05	0.000124	CcSEcCtD
Bimatoprost—Somnolence—Doxorubicin—hematologic cancer	5.52e-05	0.000124	CcSEcCtD
Bimatoprost—Dyspepsia—Doxorubicin—hematologic cancer	5.46e-05	0.000123	CcSEcCtD
Bimatoprost—Rash—Prednisone—hematologic cancer	5.41e-05	0.000121	CcSEcCtD
Bimatoprost—Dermatitis—Prednisone—hematologic cancer	5.4e-05	0.000121	CcSEcCtD
Bimatoprost—Headache—Prednisone—hematologic cancer	5.37e-05	0.000121	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Doxorubicin—hematologic cancer	5.36e-05	0.00012	CcSEcCtD
Bimatoprost—Pain—Doxorubicin—hematologic cancer	5.31e-05	0.000119	CcSEcCtD
Bimatoprost—Asthenia—Methotrexate—hematologic cancer	5.14e-05	0.000115	CcSEcCtD
Bimatoprost—Nausea—Prednisone—hematologic cancer	5.09e-05	0.000114	CcSEcCtD
Bimatoprost—Pruritus—Methotrexate—hematologic cancer	5.07e-05	0.000114	CcSEcCtD
Bimatoprost—Asthenia—Epirubicin—hematologic cancer	4.81e-05	0.000108	CcSEcCtD
Bimatoprost—Pruritus—Epirubicin—hematologic cancer	4.75e-05	0.000106	CcSEcCtD
Bimatoprost—Dizziness—Methotrexate—hematologic cancer	4.74e-05	0.000106	CcSEcCtD
Bimatoprost—Rash—Methotrexate—hematologic cancer	4.52e-05	0.000101	CcSEcCtD
Bimatoprost—Dermatitis—Methotrexate—hematologic cancer	4.52e-05	0.000101	CcSEcCtD
Bimatoprost—Headache—Methotrexate—hematologic cancer	4.49e-05	0.000101	CcSEcCtD
Bimatoprost—Asthenia—Doxorubicin—hematologic cancer	4.45e-05	9.99e-05	CcSEcCtD
Bimatoprost—Dizziness—Epirubicin—hematologic cancer	4.44e-05	9.95e-05	CcSEcCtD
Bimatoprost—Pruritus—Doxorubicin—hematologic cancer	4.39e-05	9.85e-05	CcSEcCtD
Bimatoprost—Nausea—Methotrexate—hematologic cancer	4.26e-05	9.55e-05	CcSEcCtD
Bimatoprost—Rash—Epirubicin—hematologic cancer	4.23e-05	9.49e-05	CcSEcCtD
Bimatoprost—Dermatitis—Epirubicin—hematologic cancer	4.23e-05	9.48e-05	CcSEcCtD
Bimatoprost—Headache—Epirubicin—hematologic cancer	4.2e-05	9.43e-05	CcSEcCtD
Bimatoprost—Dizziness—Doxorubicin—hematologic cancer	4.1e-05	9.21e-05	CcSEcCtD
Bimatoprost—Nausea—Epirubicin—hematologic cancer	3.98e-05	8.94e-05	CcSEcCtD
Bimatoprost—Rash—Doxorubicin—hematologic cancer	3.91e-05	8.78e-05	CcSEcCtD
Bimatoprost—Dermatitis—Doxorubicin—hematologic cancer	3.91e-05	8.77e-05	CcSEcCtD
Bimatoprost—Headache—Doxorubicin—hematologic cancer	3.89e-05	8.72e-05	CcSEcCtD
Bimatoprost—Nausea—Doxorubicin—hematologic cancer	3.69e-05	8.27e-05	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—CCL2—hematologic cancer	3.33e-05	0.000133	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6R—hematologic cancer	3.32e-05	0.000132	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CREBBP—hematologic cancer	3.32e-05	0.000132	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FOXO1—hematologic cancer	3.32e-05	0.000132	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PDGFRB—hematologic cancer	3.31e-05	0.000132	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PDGFRA—hematologic cancer	3.26e-05	0.00013	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—JAK1—hematologic cancer	3.25e-05	0.000129	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PRKCG—hematologic cancer	3.25e-05	0.000129	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL2RA—hematologic cancer	3.21e-05	0.000128	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MAP2K1—hematologic cancer	3.19e-05	0.000127	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL2—hematologic cancer	3.19e-05	0.000127	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TERT—hematologic cancer	3.18e-05	0.000126	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CD—hematologic cancer	3.17e-05	0.000126	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.17e-05	0.000126	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MAP2K1—hematologic cancer	3.17e-05	0.000126	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CD—hematologic cancer	3.15e-05	0.000125	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL2RA—hematologic cancer	3.14e-05	0.000125	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL2—hematologic cancer	3.12e-05	0.000124	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—PIK3CA—hematologic cancer	3.12e-05	0.000124	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TERT—hematologic cancer	3.11e-05	0.000124	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PDGFB—hematologic cancer	3.1e-05	0.000123	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—KRAS—hematologic cancer	3.08e-05	0.000123	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—FGF2—hematologic cancer	3.04e-05	0.000121	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PDGFB—hematologic cancer	3.03e-05	0.000121	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL2RA—hematologic cancer	3.03e-05	0.000121	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TSC2—hematologic cancer	3.03e-05	0.000121	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CG—hematologic cancer	3.02e-05	0.00012	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—FGF2—hematologic cancer	3.01e-05	0.00012	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TERT—hematologic cancer	3e-05	0.000119	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3R1—hematologic cancer	2.99e-05	0.000119	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3R1—hematologic cancer	2.97e-05	0.000118	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TSC2—hematologic cancer	2.97e-05	0.000118	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PDGFB—hematologic cancer	2.93e-05	0.000116	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FGFR3—hematologic cancer	2.91e-05	0.000116	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—JAK2—hematologic cancer	2.91e-05	0.000116	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—JAK2—hematologic cancer	2.89e-05	0.000115	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MAPK14—hematologic cancer	2.89e-05	0.000115	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TSC2—hematologic cancer	2.86e-05	0.000114	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FGFR3—hematologic cancer	2.85e-05	0.000113	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MDM2—hematologic cancer	2.84e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ESR1—hematologic cancer	2.83e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PIK3CA—hematologic cancer	2.83e-05	0.000113	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MAPK14—hematologic cancer	2.82e-05	0.000112	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MDM2—hematologic cancer	2.82e-05	0.000112	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CREBBP—hematologic cancer	2.8e-05	0.000111	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FN1—hematologic cancer	2.8e-05	0.000111	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ESR1—hematologic cancer	2.77e-05	0.00011	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MTOR—hematologic cancer	2.76e-05	0.00011	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CB—hematologic cancer	2.76e-05	0.00011	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NFKBIA—hematologic cancer	2.76e-05	0.00011	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—BAD—hematologic cancer	2.76e-05	0.00011	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CD4—hematologic cancer	2.76e-05	0.00011	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FGFR3—hematologic cancer	2.75e-05	0.000109	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MTOR—hematologic cancer	2.74e-05	0.000109	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CB—hematologic cancer	2.74e-05	0.000109	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FN1—hematologic cancer	2.74e-05	0.000109	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOTCH1—hematologic cancer	2.74e-05	0.000109	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MAPK14—hematologic cancer	2.72e-05	0.000108	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—BAD—hematologic cancer	2.7e-05	0.000108	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NFKBIA—hematologic cancer	2.7e-05	0.000108	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CD80—hematologic cancer	2.68e-05	0.000107	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOTCH1—hematologic cancer	2.68e-05	0.000107	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CG—hematologic cancer	2.68e-05	0.000106	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KIT—hematologic cancer	2.68e-05	0.000106	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—NRAS—hematologic cancer	2.68e-05	0.000106	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ESR1—hematologic cancer	2.67e-05	0.000106	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CD—hematologic cancer	2.66e-05	0.000106	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FN1—hematologic cancer	2.64e-05	0.000105	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTPN11—hematologic cancer	2.63e-05	0.000105	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CD80—hematologic cancer	2.62e-05	0.000104	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ALB—hematologic cancer	2.62e-05	0.000104	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CG—hematologic cancer	2.62e-05	0.000104	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KIT—hematologic cancer	2.62e-05	0.000104	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—NRAS—hematologic cancer	2.62e-05	0.000104	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—HRAS—hematologic cancer	2.62e-05	0.000104	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—BAD—hematologic cancer	2.61e-05	0.000104	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NFKBIA—hematologic cancer	2.61e-05	0.000104	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CDKN1B—hematologic cancer	2.59e-05	0.000103	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOTCH1—hematologic cancer	2.58e-05	0.000103	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTPN11—hematologic cancer	2.57e-05	0.000102	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CDKN1B—hematologic cancer	2.57e-05	0.000102	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—MAPK3—hematologic cancer	2.56e-05	0.000102	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CREB1—hematologic cancer	2.55e-05	0.000101	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—AKT1—hematologic cancer	2.54e-05	0.000101	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CD80—hematologic cancer	2.53e-05	0.000101	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CG—hematologic cancer	2.53e-05	0.000101	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KIT—hematologic cancer	2.53e-05	0.000101	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CASP3—hematologic cancer	2.52e-05	0.0001	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL2—hematologic cancer	2.52e-05	0.0001	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—BRAF—hematologic cancer	2.51e-05	0.0001	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3R1—hematologic cancer	2.51e-05	9.98e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—MAPK3—hematologic cancer	2.51e-05	9.98e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL6—hematologic cancer	2.51e-05	9.97e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CREB1—hematologic cancer	2.49e-05	9.92e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCL2—hematologic cancer	2.49e-05	9.91e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6R—hematologic cancer	2.48e-05	9.88e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTPN11—hematologic cancer	2.48e-05	9.87e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CREBBP—hematologic cancer	2.48e-05	9.87e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—BRAF—hematologic cancer	2.46e-05	9.79e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CCND1—hematologic cancer	2.45e-05	9.76e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—JUN—hematologic cancer	2.45e-05	9.74e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCL2—hematologic cancer	2.44e-05	9.7e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6R—hematologic cancer	2.43e-05	9.67e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CREBBP—hematologic cancer	2.43e-05	9.66e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CREB1—hematologic cancer	2.4e-05	9.57e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CDKN1A—hematologic cancer	2.39e-05	9.53e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PTEN—hematologic cancer	2.39e-05	9.5e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—BRAF—hematologic cancer	2.37e-05	9.45e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CDKN1A—hematologic cancer	2.37e-05	9.45e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PTEN—hematologic cancer	2.37e-05	9.42e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MAP2K1—hematologic cancer	2.37e-05	9.42e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCL2—hematologic cancer	2.35e-05	9.36e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CD—hematologic cancer	2.35e-05	9.36e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6R—hematologic cancer	2.35e-05	9.33e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CREBBP—hematologic cancer	2.34e-05	9.32e-05	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PIK3CA—hematologic cancer	2.33e-05	9.27e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MAPK8—hematologic cancer	2.32e-05	9.22e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MAP2K1—hematologic cancer	2.32e-05	9.22e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CB—hematologic cancer	2.32e-05	9.21e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—AKT1—hematologic cancer	2.31e-05	9.19e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—KRAS—hematologic cancer	2.3e-05	9.16e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CD—hematologic cancer	2.3e-05	9.16e-05	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.28e-05	9.07e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EP300—hematologic cancer	2.28e-05	9.06e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EP300—hematologic cancer	2.26e-05	8.99e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—KRAS—hematologic cancer	2.25e-05	8.97e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FGF2—hematologic cancer	2.25e-05	8.96e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MAP2K1—hematologic cancer	2.24e-05	8.89e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CD—hematologic cancer	2.22e-05	8.84e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3R1—hematologic cancer	2.22e-05	8.84e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SRC—hematologic cancer	2.22e-05	8.81e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FGF2—hematologic cancer	2.2e-05	8.77e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SRC—hematologic cancer	2.2e-05	8.74e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3R1—hematologic cancer	2.17e-05	8.65e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—JAK2—hematologic cancer	2.16e-05	8.59e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VEGFA—hematologic cancer	2.14e-05	8.51e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—STAT3—hematologic cancer	2.14e-05	8.5e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NRAS—hematologic cancer	2.13e-05	8.48e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FGF2—hematologic cancer	2.13e-05	8.46e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—STAT3—hematologic cancer	2.12e-05	8.43e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PIK3CA—hematologic cancer	2.12e-05	8.42e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NRAS—hematologic cancer	2.11e-05	8.41e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—JAK2—hematologic cancer	2.11e-05	8.41e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MDM2—hematologic cancer	2.11e-05	8.38e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3R1—hematologic cancer	2.1e-05	8.34e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PIK3CA—hematologic cancer	2.07e-05	8.24e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MDM2—hematologic cancer	2.06e-05	8.2e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MTOR—hematologic cancer	2.05e-05	8.16e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CB—hematologic cancer	2.05e-05	8.16e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MAPK3—hematologic cancer	2.04e-05	8.12e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—JAK2—hematologic cancer	2.04e-05	8.11e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MAPK3—hematologic cancer	2.02e-05	8.05e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MTOR—hematologic cancer	2.01e-05	7.98e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CB—hematologic cancer	2.01e-05	7.98e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PTEN—hematologic cancer	2e-05	7.96e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MDM2—hematologic cancer	1.99e-05	7.92e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MYC—hematologic cancer	1.99e-05	7.9e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TGFB1—hematologic cancer	1.98e-05	7.88e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MYC—hematologic cancer	1.97e-05	7.83e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TGFB1—hematologic cancer	1.96e-05	7.81e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—HRAS—hematologic cancer	1.96e-05	7.79e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MTOR—hematologic cancer	1.94e-05	7.7e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CB—hematologic cancer	1.94e-05	7.7e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CDKN1B—hematologic cancer	1.92e-05	7.65e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—HRAS—hematologic cancer	1.92e-05	7.62e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—EP300—hematologic cancer	1.91e-05	7.59e-05	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—AKT1—hematologic cancer	1.9e-05	7.57e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CASP3—hematologic cancer	1.89e-05	7.5e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CDKN1B—hematologic cancer	1.88e-05	7.49e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL2—hematologic cancer	1.88e-05	7.49e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL6—hematologic cancer	1.87e-05	7.45e-05	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—AKT1—hematologic cancer	1.86e-05	7.41e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CASP3—hematologic cancer	1.85e-05	7.34e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL2—hematologic cancer	1.84e-05	7.33e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CCND1—hematologic cancer	1.84e-05	7.3e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—KRAS—hematologic cancer	1.83e-05	7.3e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL6—hematologic cancer	1.83e-05	7.29e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—JUN—hematologic cancer	1.83e-05	7.29e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—KRAS—hematologic cancer	1.82e-05	7.24e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CDKN1B—hematologic cancer	1.82e-05	7.23e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CCND1—hematologic cancer	1.8e-05	7.15e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—JUN—hematologic cancer	1.79e-05	7.13e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CASP3—hematologic cancer	1.78e-05	7.08e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL2—hematologic cancer	1.78e-05	7.07e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CDKN1A—hematologic cancer	1.78e-05	7.06e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTEN—hematologic cancer	1.77e-05	7.05e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CDKN1A—hematologic cancer	1.74e-05	6.91e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTEN—hematologic cancer	1.73e-05	6.9e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CCND1—hematologic cancer	1.73e-05	6.9e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MAPK8—hematologic cancer	1.73e-05	6.89e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—JUN—hematologic cancer	1.73e-05	6.88e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—AKT1—hematologic cancer	1.73e-05	6.88e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MAPK8—hematologic cancer	1.7e-05	6.75e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—AKT1—hematologic cancer	1.69e-05	6.73e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EP300—hematologic cancer	1.69e-05	6.72e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PIK3CA—hematologic cancer	1.69e-05	6.7e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CDKN1A—hematologic cancer	1.68e-05	6.67e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTEN—hematologic cancer	1.67e-05	6.66e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PIK3CA—hematologic cancer	1.67e-05	6.65e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EP300—hematologic cancer	1.65e-05	6.58e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SRC—hematologic cancer	1.64e-05	6.54e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MAPK8—hematologic cancer	1.64e-05	6.51e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TP53—hematologic cancer	1.62e-05	6.43e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SRC—hematologic cancer	1.61e-05	6.4e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VEGFA—hematologic cancer	1.6e-05	6.37e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EP300—hematologic cancer	1.6e-05	6.35e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—STAT3—hematologic cancer	1.58e-05	6.3e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NRAS—hematologic cancer	1.58e-05	6.29e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VEGFA—hematologic cancer	1.57e-05	6.23e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HRAS—hematologic cancer	1.56e-05	6.2e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SRC—hematologic cancer	1.55e-05	6.17e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—STAT3—hematologic cancer	1.55e-05	6.17e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NRAS—hematologic cancer	1.55e-05	6.15e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HRAS—hematologic cancer	1.55e-05	6.15e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MAPK3—hematologic cancer	1.51e-05	6.02e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VEGFA—hematologic cancer	1.51e-05	6.01e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—STAT3—hematologic cancer	1.5e-05	5.95e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NRAS—hematologic cancer	1.49e-05	5.94e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IL6—hematologic cancer	1.49e-05	5.94e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MAPK3—hematologic cancer	1.48e-05	5.89e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6—hematologic cancer	1.48e-05	5.89e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MYC—hematologic cancer	1.47e-05	5.86e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TGFB1—hematologic cancer	1.47e-05	5.84e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MYC—hematologic cancer	1.44e-05	5.73e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TGFB1—hematologic cancer	1.44e-05	5.72e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MAPK3—hematologic cancer	1.43e-05	5.69e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PIK3CA—hematologic cancer	1.41e-05	5.61e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MYC—hematologic cancer	1.39e-05	5.53e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TGFB1—hematologic cancer	1.39e-05	5.52e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—AKT1—hematologic cancer	1.38e-05	5.48e-05	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—AKT1—hematologic cancer	1.37e-05	5.43e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KRAS—hematologic cancer	1.36e-05	5.41e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KRAS—hematologic cancer	1.33e-05	5.3e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KRAS—hematologic cancer	1.28e-05	5.11e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PIK3CA—hematologic cancer	1.25e-05	4.97e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PIK3CA—hematologic cancer	1.22e-05	4.87e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TP53—hematologic cancer	1.21e-05	4.81e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TP53—hematologic cancer	1.18e-05	4.71e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PIK3CA—hematologic cancer	1.18e-05	4.7e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HRAS—hematologic cancer	1.16e-05	4.6e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—AKT1—hematologic cancer	1.15e-05	4.59e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TP53—hematologic cancer	1.14e-05	4.54e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HRAS—hematologic cancer	1.13e-05	4.5e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6—hematologic cancer	1.11e-05	4.4e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HRAS—hematologic cancer	1.09e-05	4.34e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6—hematologic cancer	1.08e-05	4.31e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6—hematologic cancer	1.05e-05	4.16e-05	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—AKT1—hematologic cancer	1.02e-05	4.06e-05	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—AKT1—hematologic cancer	9.99e-06	3.98e-05	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—AKT1—hematologic cancer	9.64e-06	3.84e-05	CbGpPWpGaD
